Brian Patrick McNulty sold $392k of MIRA
owner at MIRA PHARMACEUTICALS, INC.. 200,000 shares at an average of $1.96, traded Aug 28, 2024, filed Aug 30, 2024.
Score components
- +12Role10% owner
- +16Trade size$392k at market
- 0Share of holdings soldSold 7.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -39.9%, 3m -33.2%, 6m -48.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-034584, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 28, 2024 | SOpen-market sale Common Stockindirect: By Trust | -200,000 | $1.96 | $392k | 2,540,270 | Aug 30, 2024 |
Related signals
Other insiders at MIRA PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 16Weak | MIRA PHARMACEUTICALS, INC. | Erez Aminov Chief Executive Officer | $134k 100,000 shares | -9% | |
| 33Weak | MIRAbuy MIRA PHARMACEUTICALS, INC. | Erez Aminov Chief Executive Officer | $8,176 8,700 shares | +2% | |
| 33Weak | MIRAsell MIRA PHARMACEUTICALS, INC. | Brian Patrick McNulty owner | $726k 238,095 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.